Regulatory role of transcription factor HBP1 in anticancer efficacy of EGFR inhibitor erlotinib in HNSCC.

Head & Neck
Chien-Yi ChanChunyin Huang

Abstract

Epidermal growth factor receptor (EGFR) is often hyperactivated in head and neck squamous cell carcinoma (HNSCC); however, its downstream mediators are not fully identified. Here, we investigate the role of transcription factor HBP1 in the anticancer efficacy of EGFR inhibitor erlotinib in HNSCC. The effect of erlotinib and HBP1 on cell proliferation and invasion was examined by flow cytometric analysis and a Matrigel invasion assay, respectively. Oral tumor specimens were used to evaluate the association between the expression level of EGFR and HBP1, and metastatic potential. Erlotinib caused cell growth arrest in the G1 phase and sluggish invasion with a concomitant increase in HBP1 and p27 expression. The erlotinib effect was attenuated upon HBP1 knockdown. Analysis of oral tumor specimens revealed that the low HBP1/high EGFR status can predict metastatic potential. Our data support HBP1 as a crucial mediator of EGFR-targeting inhibitors in HNSCC.

References

Jul 22, 1998·Molecular and Cellular Biology·H H ShihA S Yee
Mar 22, 2003·Experimental Cell Research·Robert N JorissenAntony W Burgess
Jan 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Denis SoulieresLillian L Siu
Mar 17, 2004·Molecular and Cellular Biology·Stephen P BerasiK Eric Paulson
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 15, 2005·The New England Journal of Medicine·Ming-Sound TsaoFrances A Shepherd
Jul 30, 2005·Expert Opinion on Biological Therapy·Barbara Burtness
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John R JohnsonRichard Pazdur
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara BurtnessUNKNOWN Eastern Cooperative Oncology Group
Sep 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine H ChungFred R Hirsch
Sep 13, 2006·Molecular and Cellular Biology·Xiaowei ZhangAmy S Yee
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephane TemamLi Mao
Dec 7, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fabienne ThomasJean-Pierre Delord
Mar 5, 2009·Cellular Signalling·Vladimir RatushnyJoshua S Silverman
Oct 15, 2009·Anti-cancer Drugs·Helmout Modjtahedi, Sharadah Essapen
Dec 17, 2009·The Journal of Biological Chemistry·Julienne R Escamilla-PowersRosalie Sears
Oct 5, 2011·Nucleic Acids Research·Weibin WangXiaowei Zhang
Apr 13, 2012·Journal of Cellular Physiology·Chun-Yin HuangMing-Fen Lee
Dec 3, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yi ShaoChonggang Pei

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.